肺表面活性物质在新生儿呼吸窘迫综合征治疗中的应用价值

Application Value of Pulmonary Surfactant in the Treatment of Neonatal Respiratory Distress Syndrome

目的探究新生儿呼吸窘迫综合征运用肺表面活性物质治疗的应用价值。方法选取2015年1月—2017年5月本院收治的新生儿呼吸窘迫综合征患者110例作为研究对象。按随机分组原则,将其分为观察组(肺表面活性物质治疗)与对照组(常规治疗),每组各55例患者。统计两组患者的治疗效果、血气分析及心率等指标改善状况。结果观察组患者的治疗总有效率为96.36%,高于对照组患者;且观察组患者的血气分析、心率、呼吸频率、血气中pH各指标改善明显,与对照组比较,差异均具有统计学意义(P<0.05)。结论新生儿呼吸窘迫综合征运用肺表面活性物质治疗后,可使治疗效果提高,改善患肺功能各指标。

Objective To explore the application value of neonatal respiratory distress syndrome in the treatment of pulmonary surfactant. Methods 110 cases of neonatal respiratory distress syndrome treated in our hospital from January 2015 to May 2017 were selected as the research objects. According to the principle of random grouping, they were divided into observation group （pulmonary surfaetant treatment） and control group （conventional treatment）, 55 patients in each group. The treatment effect, blood gas analysis and heart rate of the two groups were compared. Results The total effective rate of the observation group was 96.36%, which was higher than that of the control group. The blood gas analysis, heart rate,respiratory rate, blood gas pH indexes in the observation group were significantly improved, compared with the control group, the differences were statistically significant （P 〈 0.05）. Conclusion The treatment of neonatal respiratory distress syndrome with pulmonary surfactant can improve the therapeutic effect and improve the lung function.